Answers are grounded in this paper and cite their sources.
Masterclass refutes myths and highlights evidence-based practices for gluteal tendinopathy management.
Gluteal tendinopathy is a prevalent and impactful condition. For many decades clinical practice has been guided by ‘myths’ that developed around clinical beliefs. It’s time to examine these myths and engage with the substantial evidence base. This masterclass aims to: (i) engage with the evidence to refute the most common myths associated with gluteal tendinopathy and trochanteric pain, and (ii) provide clinicians with guidance around contemporary, evidence-based clinical practice. It is time to put aside traditional beliefs that focused on anti-inflammatory treatments, including rest and corticosteroid injections as first line management for trochanteric pain. Contemporary management of tendinopathy takes an active approach that empowers the individual to manage their own condition through education, load management, progressive exercise and optimisation of their general health. The body of evidence for gluteal tendinopathy supports health professionals in employing such principles with greater confidence. • Gluteal tendinopathy (GT) is a prevalent and impactful condition. • Diagnosis and treatment of GT has been guided by many ‘myths’ for too long. • There is now a substantial body of evidence to guide clinical practice. • It’s time to dispel the myths by engaging with the evidence. • Contemporary diagnostic and management strategies for GT are presented.
No takes yet. Share an insight, caveat, or question.
Grimaldi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: